BEACON Pharma Ltd Launched First Global Generic of Crizotinib
BEACON pharmaceuticals Ltd. (BPL), one of Bangladesh’s leading generic pharmaceutical companies, announced the launch of ‘Crizotinib’ internationally for the treatment of metastatic Non-Small Cell Lung Cancer under the brand name ‘Crizonix’.Crizonix is the 1st global generic of Crizotinib. The product has been approved by FDA and has been recommended as a first-line treatment for both ALK [...]